Chair: Michal Lotem, Israel
TBD
Claudio Sette
Principal Investigator, Catholic University of the Sacred Heart, School of Medicine, Rome, Italy
A novel splice site polymorphism-guided adoptive immunotherapy for hematologic malignancies
Andrei Thomas-Tikhonenko
Director of Experimental Pathology, Children’s Hospital of Philadelphia, PA, USA
TBD
Oren Bogin, Israel
Chair: Caroline Robert, France
RNA quality control through m6A modification
Julian König
Chair of Biochemistry and RNA-Biology, Theodor-Boveri-Institute, Julius Maximilian University of Würzburg, Germany
A Critical View of Anti-Cancer Cell Therapies and the Alternatives Offered by mRNA
Michal Lotem
Head of the Hadassah Cancer Research Institute (HCRI), Hadassah Hebrew University Medical Center, Jerusalem, Israel
